Symbiosis II sells multiple CLNN shares (NASDAQ: CLNN) in early 2026

Rhea-AI Filing Summary

CLNN reports multiple proposed and executed sales of Common Stock by Symbiosis II LLC as disclosed on Form 144. The filing lists numerous open-market dispositions on dated entries, including 31,297 shares on 03/31/2026 for $152,316.52 and 32,705 shares on 01/12/2026 for $179,867.17. Transactions are shown across January–March 2026 with individual trade sizes and cash amounts reported per line item.

Key Figures

Trade example: 31,297 shares Proceeds example: $152,316.52 Trade example: 32,705 shares +2 more

5 metrics

Trade example 31,297 shares 03/31/2026 transaction

Proceeds example $152,316.52 cash amount for 03/31/2026 trade

Trade example 32,705 shares 01/12/2026 transaction

Proceeds example $179,867.17 cash amount for 01/12/2026 trade

Single-line entry 125,706 listed near 'Securities To Be Sold' (06/20/2023 line item)

Key Terms

Form 144, Open Market Purchase, Issuer, Common

4 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Open Market Purchase market

"Open Market Purchase | Issuer | 125706 | 06/20/2023"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

Issuer regulatory

"Open Market Purchase | Issuer | 125706"

Common financial

"Common | Symbiosis II LLC ... | Common | 03/31/2026 | 31297"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California St Ste 1800 San Francisco CA 94104	30518	149233.02	11778307	03/24/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/20/2023	Open Market Purchase	Issuer			125706	06/20/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	12/31/2025	13095	76054.07
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/02/2026	4015	22996.19
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/05/2026	5869	34472.7
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/06/2026	3111	18791.18
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/07/2026	3938	24771.49
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/08/2026	3195	19448.5
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/09/2026	9075	56900.82
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/12/2026	32705	179867.17
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/13/2026	26105	127631.6
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/14/2026	19621	100496.05
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/15/2026	12563	64040.34
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/16/2026	7923	40626.13
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/20/2026	12432	59731.78
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/21/2026	12119	61227.75
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/22/2026	12665	67323.13
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/23/2026	5556	29256.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/26/2026	6418	32186.97
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/27/2026	4139	21016.06
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/28/2026	8717	42789.36
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	3810	15843.2
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/29/2026	11474	50113.36
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	01/30/2026	5686	23493.07
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/02/2026	2050	8262.02
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/02/2026	1750	7102.19
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	02/03/2026	5559	22818.28
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/24/2026	5492	31722.97
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/25/2026	7098	39045.14
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/26/2026	5319	28705.91
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/27/2026	17470	82908.17
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/30/2026	15536	79283.66
Symbiosis II LLC 609 SW 8th St Ste 510 Bentonville AR 72712	Common	03/31/2026	31297	152316.52

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CLNN show?

It lists proposed and completed sales of Common Stock by Symbiosis II LLC. The filing details multiple open-market dispositions on specific dates with per-trade share counts and cash amounts, spanning January through March 2026.

How many shares did Symbiosis II LLC sell on 03/31/2026 in the CLNN filing?

Symbiosis II LLC sold 31,297 shares on 03/31/2026. The transaction is reported with a cash value of $152,316.52 in the filing's line-item for that date.

Are the CLNN sales shown as open-market transactions?

Yes — the filing lists open-market purchases/sales for the securities shown. Individual lines identify trades marked as open-market entries with dates and cash proceeds for each disposition.

Does the CLNN filing show total aggregated proceeds or a cumulative share total?

The excerpt provides per-transaction share counts and cash amounts only. The filing lists individual trade lines; it does not present a single aggregated proceeds total in the provided content.

Who is the reporting party in the CLNN Form 144 entries?

The transactions are reported for Symbiosis II LLC. The filing includes Symbiosis II LLC's address and multiple dated common-share dispositions attributed to that entity.